ADME/TK Evaluation (S0875) of Di-n-butyltin dichloride (683-18-1) in F344 Rats Exposed via Gavage Administration or Intravenous Injection
Radiolabel Description:
Carbon-14 located on the carbons attached to the Sn; (CH3CH2CH2*CH2)2Sn
Vehicles:
Intravenous, 0.9% saline:Alkamuls (4:1); Oral, 0.9% saline:Alkamuls (4:1).
Summary Data - Male Rats
- Gavage Multiple Dose 10X (0.1 mg/kg, Study Duration 70 days post last dose) (57KB)
- Gavage Multiple Dose 10X (0.1 mg/kg, Study Duration to 14 days) (33KB)
- Gavage Multiple Dose 5X (0.1 mg/kg, Study Duration 3 days post last dose) (40KB)
- Gavage Multiple Dose 5X and 10X (0.1 mg/kg, Study Duration 3 or 18 days post last dose) (32KB)
- Gavage Single Dose (0.09 mg/kg, Study Duration 72 hours) Tissue (40KB)
- Gavage Single Dose (0.09, 1.1, or 11 mg/kg, Study Duration 72 hours) Excreta & Summary (38KB)
- Gavage Single Dose (0.1 mg/kg, Study Duration 8 hours) Summary (26KB)
- Gavage Single Dose (0.1 mg/kg, Study Duration 8 hours) Tissue (39KB)
- Gavage Single Dose (0.10 mg/kg, Excreta with Bile, Study Duration 24 hours) Summary (37KB)
- Gavage Single Dose (0.10 mg/kg, Excreta with Bile, Study Duration 24 hours) Tissue (39KB)
- Gavage Single Dose (1.1 mg/kg, Study Duration 72 hours) Tissue (41KB)
- Gavage Single Dose (10.0 mg/kg, Study Duration 8 hours) Summary (37KB)
- Gavage Single Dose (10.0 mg/kg, Study Duration 8 hours) Tissue (40KB)
- Gavage Single Dose (11 mg/kg, Study Duration 72 hours) Tissue (40KB)
- Gavage Single Dose (12.0 mg/kg, Excreta with Bile, Study Duration 8 hours) (37KB)
- Gavage Single Dose (13.0 mg/kg, Helicobacter Infected, Study Duration 8 hours) Summary (37KB)
- Gavage Single Dose (13.0 mg/kg, Helicobacter Infected, Study Duration 8 hours) Tissue (43KB)
- IV Single Dose (0.11 mg/kg, Excreta with Bile, Study Duration 24 hours) Summary (39KB)
- IV Single Dose (0.11 mg/kg, Excreta with Bile, Study Duration 24 hours) Tissue (39KB)